title: [Heart transplant in "Nuevo Leon": the first 33 cases].
abstract: Heart failure is one of the most important causes of death worldwide. Heart transplant is the last effective alternative when the medical and surgical treatments have failed in patients with end stage heart failure, giving them an 80% one year survival rate. Unfortunately, during the outcome, the heart transplant patients can develop complications such as graft rejection and opportunistic infections because of the use of immunosuppressive therapy. In the present article we report the experience with 33 heart transplant patients. Our program not only has successfully transplanted patients with advanced age but, for the first time in Latin America we have transplanted patients assisted with the ambulatory Thoratec TLC II system. Even with limited resources, we have managed the same complications than other heart transplant programs, our 82% one year survival rate is similar than reports in medical literature.
authors.affiliation: IMSS Monterrey, Hospital San José TEC de Monterrey. eduardoherrera@intercable.net
authors.forename: Eduardo
authors.initials: E
authors.lastname: Herrera Garza
authors.forename: Julio
authors.initials: J
authors.lastname: Molina Gamboa
authors.forename: Horacio
authors.initials: H
authors.lastname: Decanini Arcaute
authors.forename: Marcos
authors.initials: M
authors.lastname: Ibarra Flores
authors.forename: Myrella
authors.initials: M
authors.lastname: Torres García
authors.forename: Carlos
authors.initials: C
authors.lastname: Macías Hidalgo
authors.forename: Roberto
authors.initials: R
authors.lastname: González Oviedo
authors.forename: Felipe de Jesús
authors.initials: Fde J
authors.lastname: de la Fuente Magallanes
authors.forename: Lius Angel
authors.initials: LA
authors.lastname: Elizondo Sifuentes
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: Villarreal Arredondo
authors.forename: Oscar
authors.initials: O
authors.lastname: Ortega Durán
authors.forename: Pedro
authors.initials: P
authors.lastname: Martínez Bermúdez
authors.forename: Armando
authors.initials: A
authors.lastname: García Castillo
authors.forename: Oralia
authors.initials: O
authors.lastname: Becerra García
authors.forename: Diana
authors.initials: D
authors.lastname: Martínez Rodríguez
authors.forename: Carmen
authors.initials: C
authors.lastname: Contreras Lara
authors.forename: María de Consuelo
authors.initials: Mde C
authors.lastname: Olivares de la Cerda
authors.forename: Alfonso
authors.initials: A
authors.lastname: Treviño Treviño
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D016027:Heart Transplantation / Q000009:adverse effects / Q000706:statistics & numerical data*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008800:Mexico; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology
chemical_list: D007166:Immunosuppressive Agents